Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-001573
Filing Date
2021-01-06
Accepted
2021-01-06 17:00:44
Documents
1
Period of Report
2021-01-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm211898-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm211898-2_4seq1.xml 4 4273
  Complete submission text file 0001104659-21-001573.txt   5986
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Issuer) CIK: 0001425205 (see all company filings)

EIN.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address
GRAF FINCKENSTEIN FRIEDRICH (Reporting) CIK: 0001782981 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36860 | Film No.: 21511450